The import of Phenazone to Germany from 2024 to 2028 is forecasted to gradually decrease from 440.33 (thousand kilograms) in 2024 to 399.66 in 2028. The year-by-year reduction indicates a consistent declining trend of approximately 2.4% annually. This downward trend may reflect changes in domestic demand or international market conditions. The compound annual growth rate (CAGR) over this five-year period is expected to be negative, showcasing an average reduction per year.
Future trends to watch for include potential shifts in regulatory policies affecting importation, developments in alternative medication availability, and broader economic factors impacting the pharmaceutical industry's supply chain dynamics.
